Segesterone Acetate/Ethinyl Estradiol 12-Month Contraceptive Vaginal System Safety Evaluation

OBJECTIVES: To evaluate the safety outcomes from clinical studies of a 12-month Contraceptive Vaginal System (CVS) releasing an average of segesterone acetate (SA) 150 mcg and ethinyl estradiol (EE) 13 mcg daily. STUDY DESIGN: We integrated clinical safety data from nine studies of the CVS. Four stu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Contraception
Glavni autori: Gemzell-Danielsson, Kristina, Sitruk-Ware, Regine, Creinin, Mitchell D., Thomas, Michael, Barnhart, Kurt T., Creasy, George, Sussman, Heather, Alami, Mohcine, Burke, Anne E., Weisberg, Edith, Fraser, Ian, Miranda, Marie-José, Gilliam, Melissa, Liu, James, Carr, Bruce, Plagianos, Marlena, Roberts, Kevin, Blithe, Diana
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357828/
https://ncbi.nlm.nih.gov/pubmed/30831102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.02.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items